Psychotropic medications
Introduction
The provision of psychotropic medications is an important element for a health system. These medications can be used to treat the symptoms of mental disorders, reduce disability and prevent relapse. Anti-psychotics, anti-depressants, mood stabilizers and anti-epileptic medications comprise the main categories of psychotropic medications.
In the Eastern Mediterranean Region, almost all countries have pyschotropic medications in their national essential medicines lists, however, according to an assessment carried out using the WHO Assessment Instrument for Mental Health Systems (WHO-AIMS), only in 36% of countries in the Region do primary health care facilities have a regular supply of essential pyschotropic medications. As reflected in the regional strategy, countries need to ensure a regular supply of essential pyschotropic medications to all health facilities, including primary health care facilities to facilitate integration of a mental health component in primary health care. WHO has recently developed guidelines for pharmacological treatment of mental disorders in primary health care which can be adapted by countries to their local context.
Information resources
Recent publications
Policy documents
Strategy for mental health and substance abuse in the Eastern Mediterranean Region 2012–2016 [pdf 52 KB] | Arabic [pdf 52 KB] | French [pdf 52 KB]
Technical paper Maternal, child and adolescent mental health: challenges and strategic directions 2010–2015 [pdf 88 KB] | Arabic [pdf 88 KB] | French [pdf 88 KB]
Links
Related topics
Related programmes
Essential medicines and pharmaceutical policies
Collaborating centres
WHO Collaborating Centre for Mental Health, Psychiatric Centre, Ibn Rushd University
WHO Collaborating Centre for Research and Training in Mental Health
WHO Collaborating Centre for Mental Health, Tehran Psychiatric Institute
WHO Collaborating Centre for Mental Health Research, Training and Substance Abuse
Mental health systems in the Eastern Mediterranean Region: report based on the WHO assessment instrument for mental health systems [pdf 2.12 MB]